Killer-Cell Immunoglobulin-Like Receptors (KIR) and HLA-Class I Heavy Chains in Ankylosing Spondylitis-Reference-Cited by-同舟云学术

Killer-Cell Immunoglobulin-Like Receptors (KIR) and HLA-Class I Heavy Chains in Ankylosing Spondylitis

Published:2014-11 Issue: Volume:75 Page:S15-S19
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev. Res.

Author:

Cauli Alberto¹,Piga Matteo¹,Dessole Grazia¹,Porru Giovanni¹,Floris Alberto¹,Vacca Alessandra¹,Desogus Elisabetta²,La Nasa Giorgio²,Mathieu Alessandro¹

Affiliation:

1. Rheumatology Unit; Department of Medical Sciences; University of Cagliari; Cagliari 090142 Italy

2. Haematology Unit; Department of Medical Sciences; University of Cagliari; Cagliari 090142 Italy

Publisher

Wiley

Subject

Drug Discovery

Reference24 articles.

1. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis;Bowness;J Immunol,2011

2. Association scan of 14,500 non-synonymous SNPs in four diseases identifies autoimmunity variants;Burton;Nat Genet,2007

3. Analysis of the HLA-B27 extended haplotypes in Sardinia discloses additional predisposing factors for ankylosing spondylitis;Cascino;Arthritis Rheum,2007

4. Th17 and interleukin 23 in the pathogenesis of psoriatic arthritis and spondyloarthritis;Cauli;J Rheumatol Suppl,2012b

5. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27 subjects: a possible further susceptibility factor for the development of disease;Cauli;Rheumatology,2002a

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic biomarkers and potential treatment targets for Ankylosing Spondylitis;2023-09-14

2. Autophagy‐dependent regulation of MHC‐I molecule presentation;Journal of Cellular Biochemistry;2023-05

3. What do we know about co-stimulatory and co-inhibitory immune checkpoint signals in ankylosing spondylitis?;Clinical and Experimental Immunology;2023-03-08

4. NK cells - Dr. Jekyll and Mr. Hyde in autoimmune rheumatic diseases;International Immunopharmacology;2022-06

5. Differences in Cellular Clearing Mechanisms of Aggregates of Two Subtypes of HLA-B27;Frontiers in Immunology;2022-01-10